Evekeo (amphetamine sulfate) and Adderall (mixed amphetamine salts) are closely related amphetamine stimulants for ADHD, but Evekeo uses a single-salt racemic amphetamine formula rather than Adderall’s four-salt, 3:1 dextro-to-levo mixture, and it also comes in an orally disintegrating tablet form Adderall does not offer. This guide compares their formulations, approved uses, and dosing.
This is general information, not medical advice. Both are Schedule II controlled substances.
Evekeo vs Adderall at a glance
| Evekeo (amphetamine sulfate) | Adderall (mixed amphetamine salts) | |
|---|---|---|
| Active drug | Racemic amphetamine sulfate (single salt) | Four salts, 3:1 dextro-to-levo amphetamine ratio |
| FDA-approved for | Narcolepsy, ADHD | ADHD, narcolepsy |
| Special form | Evekeo ODT (orally disintegrating tablet) | No ODT version |
| Initial US approval | 1984 | 1996 (brand); dextroamphetamine much older |
| Schedule | II | II |
What each is approved for
Evekeo is indicated for narcolepsy and attention deficit disorder with hyperactivity, essentially the same dual indication amphetamine-class stimulants have long carried. It also has an ODT sibling product, Evekeo ODT, indicated for ADHD specifically in children 6 to 17.
Adderall (immediate-release) is approved for ADHD and narcolepsy as well; Adderall XR is approved for ADHD only. The two drugs’ core approved uses substantially overlap.
The formulation difference that actually matters
Evekeo’s active ingredient is amphetamine sulfate in its racemic form, meaning it contains equal parts of the d- and l- amphetamine isomers, rather than the 3:1 dextro-to-levo ratio Adderall uses. The label notes that racemic amphetamine’s l-isomer is more potent than the d-isomer for cardiovascular activity but considerably less potent for the central nervous system excitatory effects that drive ADHD symptom control, meaning the ratio of isomers genuinely changes the balance of effects a patient experiences, not just the total dose.
Adderall’s four-salt combination (a mix of amphetamine and dextroamphetamine salts) is formulated specifically at a 3:1 dextro-to-levo ratio, which shifts the balance further toward the more CNS-stimulating dextro form relative to Evekeo’s even 1:1 racemic mixture.
Evekeo ODT: a formulation option Adderall doesn’t have
Evekeo also comes as an orally disintegrating tablet, dissolving in the mouth rather than requiring swallowing with water. This can be useful for children or others who have difficulty swallowing pills. A crossover pharmacokinetic study found that the ODT form, dissolved in the oral cavity, produced comparable amphetamine exposure to the standard swallowed tablet at an equal dose. Adderall has no equivalent ODT product; Adderall XR is a capsule that can be opened and its contents sprinkled on applesauce as its own accommodation for swallowing difficulty, but that’s a different approach than a true dissolving tablet.
Dosing
Evekeo is dosed at 5 to 60 mg per day depending on indication and response, typically in the immediate-release tablet form, given once or in divided doses through the day given its shorter duration of action as an immediate-release product.
Adderall XR is a once-daily extended-release capsule; immediate-release Adderall is generally dosed once or twice daily.
Side effects and warnings
Both carry the standard amphetamine boxed warning for abuse, misuse, and addiction, and the standard warning about sudden death in patients with structural cardiac abnormalities or serious cardiac disease treated with CNS stimulants at recommended ADHD doses. Evekeo’s label also specifically documents a risk of peripheral vasculopathy, including Raynaud’s phenomenon (a circulation problem causing fingers or toes to feel numb and cold in response to cold or stress), a warning shared broadly across amphetamine-class stimulants but called out explicitly in Evekeo’s current label. Both carry warnings about the onset or worsening of motor and verbal tics, and both list serotonin syndrome risk when combined with other serotonergic drugs or certain CYP2D6 inhibitors.
Who each might suit
Factors that may point toward Evekeo:
- Difficulty swallowing pills, where the ODT form offers a genuine formulation advantage
- Prior response specifically to racemic amphetamine rather than the dextro-shifted Adderall ratio
- A prescriber’s specific reason to favor the 1:1 isomer ratio’s different balance of CNS versus cardiovascular effects
Factors that may point toward Adderall:
- Wanting the more extensively studied, more commonly prescribed amphetamine combination
- A need for the once-daily extended-release option (Adderall XR), which Evekeo’s standard immediate-release tablet does not offer in the same way
- Established insurance coverage and pharmacy familiarity, given Adderall’s much higher prescribing volume
Frequently asked questions
Is Evekeo the same as Adderall?
No. Both are amphetamine-class stimulants, but Evekeo uses racemic (1:1) amphetamine sulfate while Adderall uses a four-salt mixture at a 3:1 dextro-to-levo ratio, a real formulation difference, not just a different brand name for the same drug.
What is Evekeo ODT?
It’s an orally disintegrating version of Evekeo that dissolves in the mouth rather than needing to be swallowed with water, approved for ADHD in children 6 to 17, based on comparable amphetamine exposure to the standard tablet in pharmacokinetic testing.
Does Evekeo treat narcolepsy?
Yes, along with attention deficit disorder with hyperactivity; immediate-release Adderall shares this narcolepsy indication as well.
What is peripheral vasculopathy, and why does Evekeo’s label mention it?
It’s a circulation problem, including Raynaud’s phenomenon, that can cause fingers or toes to feel cold, numb, or discolored. Evekeo’s label specifically documents this risk, a warning shared broadly across amphetamine stimulants.
Are Evekeo and Adderall both controlled substances?
Yes, both are Schedule II under federal law.
Why Evekeo has stayed a niche option
Despite being approved decades ago (1984), Evekeo has never reached anywhere near Adderall’s prescribing volume. Part of the reason is straightforward market history: Adderall’s specific 3:1 dextro-to-levo formulation became the dominant amphetamine combination product through the 1990s and 2000s, with generic mixed amphetamine salts now extremely well established across pharmacies and insurance formularies. Evekeo’s racemic 1:1 formula occupies a smaller niche, generally reached for when a prescriber has a specific reason to want that different isomer balance, or when a patient specifically needs the ODT swallowing-free option, rather than being a default first choice.
The Raynaud’s phenomenon warning, explained
Raynaud’s phenomenon is a condition where blood vessels in the fingers and toes overreact to cold or stress, narrowing suddenly and cutting off blood flow temporarily, causing the skin to turn white or blue and feel numb or painful before circulation returns. Stimulant medications, including Evekeo, have been associated with this effect, likely related to their action on blood vessel tone throughout the amphetamine drug class broadly. Patients or caregivers who notice color changes or numbness in fingers or toes during treatment should mention it at the next follow-up, since dose adjustment or a medication change may be warranted if it becomes bothersome or severe.
Practical considerations for the ODT option
Evekeo ODT dissolves in the mouth without water, which can help children who resist swallowing pills, or anyone with swallowing difficulty from another medical condition. Because it’s specifically studied and approved for ages 6 to 17, adult use of the ODT specifically for ADHD would generally rely on the original Evekeo tablet’s broader adult approval instead, since the ODT product’s approved age range is narrower.
Frequently asked questions (continued)
Why isn’t Evekeo prescribed as often as Adderall?
Largely due to market and prescribing history; Adderall’s specific salt combination became the dominant amphetamine product over decades, while Evekeo’s racemic formula occupies a smaller niche reached for in more specific situations.
What should I do if my fingers or toes turn white or blue while on Evekeo?
This could be Raynaud’s phenomenon, a known stimulant-associated effect. Mention it to the prescriber at the next visit; dose adjustment or a medication change may be considered if it’s bothersome.
Is Evekeo ODT approved for adults?
The ODT-specific approval covers ages 6 to 17; adult ADHD treatment with amphetamine sulfate would typically use the standard Evekeo tablet, which has a broader approved age range.